「Dual blockade of macropinocytosis and asparagine bioavailability shows synergistic anti-tumor effects on KRAS-mutant colorectal cancer」の関連論文
-
An Oncogenic Alteration Creates a Microenvironment that Promotes Tumor Progression by Conferring a Metabolic Advantage to Regulatory T Cells
-
肺がん細胞の senolysis とferroptosis において 細胞質 p21Cip1/Waf1 は防御的に作用する
-
Distinctive roles of syntaxin binding protein 4 and its action target, TP63, in lung squamous cell carcinoma: a theranostic study for the precision medicine
-
Efficacy of Immune Checkpoint Inhibitor Monotherapy for Advanced Non-Small-Cell Lung Cancer with ALK Rearrangement
-
Mutation burden-orthogonal tumor genomic subtypes delineate responses to immune checkpoint therapy
-
Metformin enhances the antitumor activity of oncolytic herpes simplex virus HF10 (canerpaturev) in a pancreatic cell cancer subcutaneous model
-
Local, multimodal intralesional therapy renders distant brain metastases susceptible to PD-L1 blockade in a preclinical model of triple-negative breast cancer.
-
Colorectal cancer-derived CAT1-positive extracellular vesicles alter nitric oxide metabolism in endothelial cells and promote angiogenesis
-
大腸癌におけるアポトーシス、ネクロトーシス、オートファジー:腫瘍の病理学的悪性度とp53タンパク発現状態との関連性について
-
Tuft cell-like carcinomas: novel cancer subsets present in multiple organs sharing a unique gene expression signature
-
Blockage of retinoic acid signaling via RARγ suppressed the proliferation of pancreatic cancer cells by arresting the cell cycle progression of the G1-S phase
-
The ratio of CD8 + lymphocytes to tumor-infiltrating suppressive FOXP3 + effector regulatory T cells is associated with treatment response in invasive breast cancer
-
Oncogenic E6 and/or E7 proteins drive proliferation and invasion of human papilloma virus‑positive head and neck squamous cell cancer through upregulation of Ror2 expression
-
Blockade of EGFR improves responsiveness to PD-1 blockade in EGFR-mutated non–small cell lung cancer
-
Targeting AURKA in treatment of peritoneal tumor dissemination in gastrointestinal cancer (本文)
-
Lack of impact of the ALDH2 rs671 variant on breast cancer development in Japanese BRCA1/2‐mutation carriers
-
Expansion of gastric intestinal metaplasia with copy number aberrations contributes to field cancerization
-
Studies on Cytotoxic Effects of Tumor Necrosis Factor-Related Apoptosis Inducing Ligand (TRAIL) to Canine Cell Lines Derived from Hemangiosarcoma and Mammary Epithelial Tumor
-
Oncogenic KRAS-expressing organoids with biliary epithelial stem cell properties give rise to biliary tract cancer in mice (本文)
-
Potential Benefits of Bevacizumab Combined With Platinum-Based Chemotherapy in Advanced Non–Small-Cell Lung Cancer Patients With EGFR Mutation
-
Functional analysis of mitochondria-mediated ovarian carcinoma immune-reactive antigen domain 2 in lung adenocarcinoma
-
Downregulation of lncRNA PVT1 inhibits proliferation and migration of mesothelioma cells by targeting FOXM1
-
Downregulation of lncRNA PVT1 inhibits proliferation and migration of mesothelioma cells by targeting FOXM1
-
Expression of urokinase-type plasminogen activator system in non-metastatic prostate cancer
-
Oncolytic Adenovirus Utilizing RNA Stabilization Mechanism Can Synergize with Chemotherapy
-
Expression of multiple immune checkpoint molecules on T cells in malignant ascites from epithelial ovarian carcinoma
-
Complex roles of the actin-binding protein Girdin/GIV in DNA damage-induced apoptosis of cancer cells
-
Glycoprotein NMB functions with growth factor signaling to induce tumorigenesis in breast cancer cells
-
Functional and genomic characterization of patient-derived xenograft model to study adaptation to mTORC1 inhibitor in clear cell renal cell carcinoma
-
MYC Upregulation Is a Useful Biomarker for Preoperative Neoadjuvant Chemotherapy Combined With Anti-EGFR in Liver Metastasis from Colorectal Cancer
-
MicroRNA profiles following telmisartan treatment in pancreatic ductal adenocarcinoma cells
-
Clinical and Basic Research for Ovarian Cancer
-
KRAS Inhibitor Resistance in MET-Amplified KRAS G12C Non–Small Cell Lung Cancer Induced By RAS- and Non–RAS-Mediated Cell Signaling Mechanisms
-
Pancreatic RECK inactivation promotes cancer formation, epithelial-mesenchymal transition, and metastasis
-
The loss of endothelin-2 exhibits an anticancer effect in A549 human lung adenocarcinoma cell line
-
PTEN is a predictive biomarker of trastuzumab resistance and prognostic factor in HER2-overexpressing gastroesophageal adenocarcinoma
-
PBK expression predicts favorable survival in colorectal cancer patients
-
Activation of BAX and BAK is an attractive combination therapy in melanoma
-
Characterization of the Anticancer Activities of Some Natural and Synthetic Compounds: Molecular Targets and Mechanism
-
Clinicopathological significance of EGFR pathway gene mutations and CRTC1/3–MAML2 fusions in salivary gland mucoepidermoid carcinoma
-
Synthetic miR-143 Inhibits Growth of HER2-Positive Gastric Cancer Cells by Suppressing KRAS Networks Including DDX6 RNA Helicase
-
Prognostic significance of plasma interleukin-6/-8 in pancreatic cancer patients receiving chemoimmunotherapy
-
Regulation of Cell Motility by La-Related Protein 4 in Ovarian Cancer Cell
-
Tumour-immune microenvironment in duodenal-type follicular lymphoma
-
Nrf2/p-Fyn/ABCB1 axis accompanied by p-Fyn nuclear accumulation plays pivotal roles in vinorelbine resistance in non-small cell lung cancer
-
DDIT4 Facilitates Lymph Node Metastasis via the Activation of NF-κB Pathway and Epithelial-Mesenchymal Transition
-
Trp53 Mutation in Keratin 5 (Krt5)-Expressing Basal Cells Facilitates the Development of Basal Squamous-Like Invasive Bladder Cancer in the Chemical Carcinogenesis of Mouse Bladder
-
Comprehensive analysis of full-length transcripts reveals novel splicing abnormalities and oncogenic transcripts in liver cancer
-
Next Generation Sequencing-Based Transcriptome Predicts Bevacizumab Efficacy in Combination with Temozolomide in Glioblastoma
-
In vivo induction of activin A-producing alveolar macrophages supports the progression of lung cell carcinoma